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Abstract
Background: A genetic study was carried out among obese and hypertensive individuals from
India to assess allelic association, if any, at three candidate loci: Apolipoprotein B (ApoB)
minisatellite and two tetranucleotide repeat loci; LPL (Lipoprotein lipase) and Leptin. Attempt has
also been made to find out whether telomere length attrition is associated with hypertension and
obese individuals.
Methods: Venous blood samples were collected from 37 normal, 35 obese and 47 hypertensive
individuals. Genomic DNA was extracted from peripheral blood mononuclear cells (PBMC) and
PCR amplifications were achieved using locus specific primers. Genotyping of ApoB minisatellite
was performed using 4% polyacrylamide gel electrophoresis (PAGE) followed by silver staining,
whereas LPL and Leptin loci were genotyped using ALF Express™ DNA sequencer. Telomere
length was determined using a recently developed real time based quantitative PCR, where the
relative telomere length was determined by calculating the relative ratio of telomere (T) and single
copy gene (S) PCR products which is expressed as T/S ratio.
Results: All the three loci are highly polymorphic, display high heterozygosity and conform to
Hardy-Weinberg's equilibrium expectations. ApoB minisatellite displayed 14 alleles, whereas LPL
and Leptin tetranucleotide loci were having 9 and 17 alleles, respectively. Interestingly two new
alleles (9 and 11 repeats) were detected at ApoB locus for the first time. The alleles at Leptin locus
were classified as Class I (lower alleles: 149-200 bp) and Class II alleles (higher alleles: >217 bp).
Higher alleles at ApoB (>39 repeats), predominant allele 9 at LPL and alleles 164 bp and 224 bp at
Leptin loci have shown allelic association with hypertensive individuals. After adjusting the influence
of age and gender, the analysis of co-variance (ANCOVA) revealed the relative telomere length (T/
S ratio) in hypertensive individuals to be (1.01 ± 0.021), which was significantly different (P < 0.001)
from obese (1.20 ± 0.023) and normal (1.22 ± 0.014) individuals. However, no significant difference
in the relative telomere length was observed among male and female individuals, although age
related decrease in telomere length was observed in these limited sample size.
Conclusion: The present study revealed that allelic association at ApoB, LPL, Leptin loci and loss
of telomere length may have strong genetic association with hypertensive individuals. However,
further study on larger sample size is needed to draw firm conclusions.
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Background
Essential hypertension and obesity both result from mul-
tiple environmental and genetic determinants. These dis-
orders are known to be closely associated with high Body
Mass Index (BMI) and have strong correlation with
increased blood pressure. Interest in identifying the candi-
date genes or highly polymorphic tandemly repeated loci
that contribute significantly to human obesity and essen-
tial hypertension is on the rise both in terms of designing
of pharmacological intervention strategies and genetic
association studies. Because there is a higher prevalence of
both hypertension and obesity in modern human popu-
lation, they represent excellent population for association
studies. Tandemly repeated sequences of human genome
such as minisatellites and microsatellites are highly varia-
ble and display a number of alleles in a population and
thus considered as informative markers for association
studies. ApoB minisatellite, LPL (Lipoprotein lipase) and
Leptin tetranucleotide loci are good candidates for associ-
ation studies as there are several reports showing that the
alleles at these loci may be associated with hypertension,
obesity and coronary heart diseases [1-7] The characteris-
tic of ApoB minisatellite, LPL and Leptin tetranucleotides
is given in table 1.
Apolipoprotein B (ApoB) gene maps to 2p24 [8] and
comprises 29 exons spanning about 42 kb [9]. Apolipo-
protein B is the main apolipoprotein of chylomicrons and
low density lipoproteins (LDL), which occurs in the
plasma in 2 main forms, apoB48 and apoB100. ApoB-100
is synthesized in the liver and is present in very low den-
sity lipoproteins and their metabolic products. It is a prin-
cipal ligand for low density lipoprotein (LDL) receptor
[10]. LDL receptors mediate the uptake of LDL from the
liver and peripheral cells; hence, Apo B-100 plays an
important role in cholesterol homeostasis. A positive rela-
tionship between coronary heart disease and low density
lipoprotein cholesterol with ApoB levels have been estab-
lished [11]. The 3' end of the apo B gene exhibits a varia-
ble number of tandemly repeated (VNTR) short A+T rich
DNA sequences [12]. Association of apoB 3' VNTR alleles
and direct clinical diagnosis of essential hypertension was
studied extensively [13]. Several alleles of this polymor-
phic locus have been found to be associated with coronary
heart disease (CHD) and myocardial infarction as well as
with various hyperlipidemias in different populations
[14], thus can lead to severe obesity too.
LPL gene maps to chromosome 8p22 [15] and comprises
10 exons spanning about 30 kb [16,17]. Lipoprotein
lipase (LPL), an enzyme plays a central role in the metab-
olism of lipoproteins by hydrolyzing the core triglycerides
of circulating very low density lipoproteins (VLDL) and
chylomicrons, thereby delivering lipoprotein derived fatty
acids to adipose tissues for storage or oxidation in muscle
[18,19]. Mutations in LPL or abnormal LPL lead to hyper-
triglyceridemia, dyslipidemia leading to various disorders
like, coronary artery disease, hypertension, obesity etc.
There are reports showing that abnormal adipose tissue
LPL activity can lead to obesity in animal models and in
humans [20,21]. Both Hypertriglyceridemia and dyslipi-
demia is a common finding in hypertensive patients and
therefore LPL gene is considered as a logical candidate
gene that could contribute to the development of hyper-
tension [22,23]. LPL tetranucleotide locus spans intron 6
of LPL gene [24,25]. Significant evidence for linkage of
systolic blood pressure, but not diastolic blood pressure
has been associated with LPL locus located on the short
arm of chromosome 8 (8p22) [26].
Leptin is called as human Obesity gene and it maps to
7q31.3 [27]. It consists of 3 exons and 2 introns, which
spans approximately 18 kb. It is a 16-kD protein (hor-
mone) mainly produced by adipose tissue that plays a
critical role in the regulation of body weight by inhibiting
food intake and stimulating energy expenditure [28].
Mutations in the gene encoding leptin are reported to
cause severe obesity in animal models [29] and humans
[30,31] indicating a direct relationship between leptin
and obesity. In humans, mutations in the Leptin gene are
a rare cause of obesity. But it has been a growing interest
in determining whether polymorphic variation in or near
the Leptin gene influences susceptibility to obesity in gen-
eral population. The highly polymorphic Leptin tetranu-
cleotide locus is located in 476 bp 3' of exon 3 of leptin
gene [32] and has been associated with obesity [33] and
hypertension [34]. Several researchers reported the evi-
dence of linkage and/or association between variation in
the Leptin gene region and traits related to obesity [35-
39]. In the first part of our investigation we aimed at stud-
ying the genetic association if any, in hypertensive and
Table 1: Characteristics of the loci studied.
Loci names ApoB LPL LEPTIN
Chromosome location 2p24 8p22 7q31.3
Repeat units (bps) (TTTTATAATTAAATA)n (TTTA)n (TTTC)n
Product range (bps) 314-1050 105-145 148-288
bp = base pairsBMC Medical Genetics 2009, 10:99 http://www.biomedcentral.com/1471-2350/10/99
Page 3 of 13
(page number not for citation purposes)
obese individuals at three candidate loci as compared to
Normal individuals.
Telomeres are DNA capping structures that protect the
ends of eukaryotic chromosome. These are specialized
nucleoprotein complexes and consist of tandem hexamer
repeats of the sequence TTAGGG at the end of the chro-
mosomes. They play an important role in maintaining
chromosome stability as well as protecting of the coding
parts of the DNA for recombination, degradation and rep-
lication damage. Telomere length is emerging as a
biomarker for aging, stress and survival [40-42]. Several
experimental methods have been developed to determine
telomere length including southern blot, fluorescence in
situ hybridization (Q-FISH) analysis [43], Flow-FISH
analysis [44] and most recently, by quantitative PCR [45].
Quantitative PCR method provides relative results about
telomere length by calculating the ratio of a PCR reaction
product from the same sample using specific primers for
telomeres and single copy gene (T/S ratio). Telomere attri-
tion is reported to be associated with several diseases like
diabetes [46,47], hypertension [48,49], coronary heart
disease [50,51] and many cancers including bladder can-
cer [52]. Limited Studies are available on loss of telomere
length and obesity [53]. Although shorter telomere length
was found in Asian Diabetes patients [46] and Coronary
Artery disease patients of Indian ethnicity [51], no Indian
data is available till date on telomere length attrition in
hypertensive and obese individuals.
In the present investigation, we have made an attempt to
determine the telomere length in random, normal,
healthy, adult individuals from hypertensive, obese and
normal individuals and assess the telomere attrition if
any, in hypertensive and obese individuals using real time
quantitative PCR.
Methods
Sample collection
Approximately 5 ml of venous blood sample was col-
lected in sterile EDTA-containing vacuutainers from a
total of 121 random, individuals (69 males and 52
females) with informed consent which was approved by
the ethic committee, Bhabha Atomic Research Centre,
Trombay, Mumbai. These samples included 47 individu-
als with essential hypertension (systolic/diastolic BP
range, 140/90 to 170/100; age range, 35 to 71 years), 35
individuals with obesity (Body Mass Index ≥ 30; age
range, 11 to 60 years) and 39 normal individuals (systo-
lic/diastolic BP range, 120/80 to 130/80 and Body Mass
Index < 30; age range, 23 to 69) as controls. Blood pres-
sure was measured using mercury sphygmomanometer.
The standard criteria adopted for hypertensive and obese
individuals were as follows: Hypertension or high blood
pressure is a medical condition, wherein the blood pres-
sure is chronically elevated. The systolic/diastolic is equal
to or under 120/80 is considered as normal individuals,
whereas systolic/diastolic pressure >140/90 is considered
as hypertensive. Another important criterion we adopted
was all the hypertensive individuals studied here were not
having diabetics or insulin resistance. Obesity is typically
evaluated by measuring BMI (Body Mass Index), calcu-
lated by dividing the subject's weight in kilograms by the
square of his/her height in meters (BMI = kg/m2). BMI of
>30.0 is considered as obese. These obese individuals
were also independent of diabetics and hypertension. All
the individuals included in this study were nonsmokers.
DNA extraction and PCR amplification
Genomic DNA was extracted from peripheral blood
mononuclear cells (PBMC) using a rapid non-enzymatic
method [54]. PCR amplification was achieved using locus
specific primers as given in table 2. The forward primers
were labeled with Cy5-dye amidite at the 5' end. The PCR
Table 2: Primer sequences.
Locus name Primer sequences
ApoB PR1 5' ATGGAAACGGAGAAATTATG 3'
ApoB PR2 5' CCTTCTCACTTGGCAAATAC 3'
LPLPR1 5'CTGACCAAGGATAGTGGGATATAG3'
LPLPR2 5'GGTAACTGAGCGAGACTGTGTCT 3'
Leptin PR1 5'AGTTCAAATAGAGGTCCAAATCA3'
Leptin PR2 5' TTCTGAGGTTGTGTCACTGGCA 3'
Tel PR1 5'GGTTTTTGAGGGTGAGGGTGAGGGTGAGGGTGAGGGT 3'
Tel PR2 5' TCCCGACTATCCCTATCCCTATCCCTATCCCTATCCCTA 3'
36B4 PR1 5' CAGCAAGTGGGAAGGTGTAATCC 3'
36B4 PR2 5' CCCATTCTATCATCAACGGGTACAA 3'
Beta globin PR1 5'GCTTCTGACACAACTGTGTTCACTAGC3'
Beta globin PR2 5'CACCAACTTCATCCACGTTCACC3'
PR1: Forward primer, PR2: Reverse primerBMC Medical Genetics 2009, 10:99 http://www.biomedcentral.com/1471-2350/10/99
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mixture contained 20 pmols of each of the primers, 100
uM of dNTPs, 1× buffer (as per the manufacturer's proto-
col) and 0.5 units of taq polymerase enzyme (Roche diag-
nostics, GmbH, Germany). The PCR amplification
protocol for ApoB is as follows: initial denaturation at
95°C for 5 minutes followed by a 30 cycles of melting
94°C for 1 minute, annealing at 55°C and extension at
72°C for one minute. For both LPL and Leptin loci, the
PCR temperature conditions are as follows: initial dena-
turation at 95°C for 5 minutes followed by a 30 cycles of
melting 94°C 30 seconds, annealing at 59°C for 30 sec
and extension at 72°C for 30 sec with a final extension at
72°C for 5 minutes.
Detection of alleles
The amplimers of ApoB locus were resolved in 4% native
Poly Acrylamide Gel Electrophoresis (PAGE) followed by
silver staining (figure 1A), whereas the alleles of LPL and
Leptin loci were resolved in 6% denaturing PAGE using
ALF Express™ DNA sequencer (GE Health Care, Uppsala,
Sweden). The sizes of ApoB alleles were determined by
using a software SEQAID [55], whereas LPL and Leptin
alleles were determined using a software Fragment man-
ager. The fluorogram showing LPL and Leptin alleles are
given in figure 1B and 1C. External ladders 107 bp, 228 bp
and 395 bp was used as external ladder. Internal ladders
and allelic ladders were used for accurate size determina-
tion. Nomenclature of alleles refers to number of repeats
i.e. allele 8 refers to 8 repeats.
Relative telomere length analysis by real time quantitative 
PCR (q-PCR)
Telomere length was determined from a total of 93 indi-
viduals (58 males and 35 females) which included 26 nor-
mal, 27 obese and 40 hypertensive individuals. Relative
telomere length was determined by using the approach as
previously described by Cawthon in 2002 [45] with a little
modification in the PCR temperature conditions. Relative
telomere length was measured from genomic DNA
obtained from peripheral blood mononuclear cells by
quantitative real time polymerase chain reaction (PCR).
This method measures the factor by which the ratio of tel-
omere repeat copy number to single - gene copy number
differs between a sample and that of a reference DNA sam-
ple. PCR amplification was achieved using telomere (T)
and single copy gene, 36B4 (encodes acidic ribosomal
phosphoprotein) primers (S) which serves as a quantita-
tive control. The mean telomere repeat gene sequence (T)
to a reference single copy gene (S) is represented as T/S
ratio which is calculated to determine the relative tel-
omere length. The expression of single copy gene (38B4)
was validated using another positive control beta-globin
gene. All the samples were run in triplicates in order to
minimize the sample to sample variation. The error value
indicates the degree of well to well variation in the 96 well
plate used for the PCR experiment. The standard error
between the replicate were approximately ≤0.05 (range:
0.02 to 0.05) in most of the samples. The telomere and
single copy gene specific primers used for the experiment
were as given in table 2.
Briefly, PCR reactions were performed in triplicate in 20 μl
reaction volumes (using 25 ng DNA sample per reaction)
for all the samples studied. The PCR reactions were per-
formed using telomere and single copy gene primers in
the same 96 well plate (LC480 light cycler from Roche
diagnostics, GmbH, Germany). The PCR mixture con-
tained 10 pmoles of each of the primers, 100 uM of each
dNTPs and 0.3 × SYBR green dye and 0.5 Units of fast taq
DNA polymerase (Roche Diagnostics, GmbH, Germany).
The PCR thermal conditions for relative telomere length
assay using telomeric primers (T) and single copy gene
primers (S) consisted of a initial denaturation of 5 min-
utes at 95°C, followed by a total of 40 cycles at 95°C for
5 seconds, 56°C for 30 seconds, and 72°C for 30 seconds
and fluorescence acquisition. Crossing points (Cp) were
determined using the Light Cycler 480 software (Roche
Diagnostics, GmbH, Germany). A standard curve derived
from serially-diluted reference DNA was generated in
order to check PCR efficiency between the plates. The
average of telomere versus single copy gene (T/S) ratio was
calculated which is proportional to telomere length of
each individual as described by Cawthon et al 2002 [45].
For quality control purposes, we have repeated many sam-
ples that were separately PCR amplified. All measure-
ments were performed in a blinded fashion without
knowledge of the clinical data.
Statistical analysis
The allele frequency, observed and expected heterozygos-
ity, correspondence to Hardy-Weinberg's equilibria were
calculated using software POPGENE32 (version 1.32)
[56]. The expected heterozygosity was calculated under
the assumption of Hardy-Weinberg equilibrium expecta-
tions [57]. Hardy-Weinberg equilibrium was evaluated
using the likelihood ratio test (G-statistics). The power of
discrimination (PD) was calculated as described by Fisher
et al (1951) [58] and Polymorphic Information content
(PIC) was calculated according to Botstein et al 1980 [59].
Association of alleles at each locus was determined by
analyzing the significant increase of allele frequencies in
hypertensive and obese individuals as compared to nor-
mal individuals.
Telomere length was determined after adjusting the influ-
ence of age and gender, if any, using analysis of Co-Vari-
ance (ANCOVA). Using analysis of variance (ANOVA),
pairwise comparisons were performed in order to see the
differences in the mean telomere length between the
groups (normal, obese and hypertensive). RegressionBMC Medical Genetics 2009, 10:99 http://www.biomedcentral.com/1471-2350/10/99
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Distribution of allele frequency in normal, obese and hypertensive individuals Figure 1
Distribution of allele frequency in normal, obese and hypertensive individuals. (A) ApoB ministaellite (B) LPL tetra-
nucleotide locus (C) Leptin tetranucleotide locus.
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analysis was performed to find out the correlation
between telomere length and age. ANOVA/ANCOVA, pair
wise comparisons and regression analysis were performed
using the software Statosoft [60].
Results
In the present investigation, three highly polymorphic
loci (one minisatellite, ApoB and two microsatellites; LPL
and Leptin) were studied in normal, obese and hyperten-
sive individuals. The distribution of the allele frequencies
at these three loci is given in table 3 and represented as
histograms in figures 1A, B, C. The statistical analysis for
all the three loci is given in table 4.
ApoB locus
At ApoB locus a total of 14 alleles (11 in normal, 8 in
obese and 13 in hypertensive) and 34 genotypes (tables 3,
4 and figure 1A) were observed. It showed a bimodal dis-
tribution with two predominant alleles (allele 37 and 39).
Allele 39 was observed to be the most predominant allele
Table 3: Distribution of allele frequencies at ApoB, LPL and Leptin loci in hypertensive, obese and normal individuals.
Locus name Allele Hypertensive Obese Normal
ApoB (repeats) Freq (obs. No) Freq (obs. No) Freq (obs. No)
9 0.022 (2) 0.030 (2)
11 - 0.029 (2) -
29 0.011 (1) - 0.015 (1)
31 0.065 (6) 0.147 (10) 0.106 (7)
33 0.033 (3) 0.088 (6) 0.151 (10)
35 0.087 (8) 0.015 (1) 0.076 (5)
37 0.250 (23) 0.353 (24) 0.288 (19)
39 0.326 (30) 0.265 (18) 0.227 (15)
41 0.087 (8) 0.074 (5) 0.030 (2)
43 0.054 (5) - 0.015 (1)
50 0.011 (1) - 0.015 (1)
52 0.033 (3) - 0.046 (3)
56 0.011 (1) - -
58 0.011 (1) 0.029 (2) -
n = 92 n = 68 n = 66
LPL (repeats) Freq (obs. No.) Freq (obs. No) Freq (obs. No)
8 0.011 (1) - 0.086 (5)
9 0.523 (46) 0.485 (32) 0.350 (20)
10 0.205 (18) 0.212 (14) 0.310 (18)
11 0.227 (20) 0.227 (15) 0.224 (13)
12 0.023 (2) 0.076 (5) 0.035 (2)
13 0.011 (1) - -
n = 88 n = 66 n = 58
Leptin (Base pairs) Freq (obs. No.) Freq (obs. No) Freq (obs. No)
148 - 0.014 (1) 0.027 (2)
152 0.213 (20) 0.257 (18) 0.243 (18)
156 0.138 (13) 0.143 (10) 0.243 (18)
160 0.064 (6) 0.043 (3) -
164 0.106 (10) 0.014 (1) 0.014 (1)
168 0.021 (2) - 0.014 (1)
172 0.011 (1) - -
204 - - 0.014 (1)
216 0.021 (2) 0.041 (1) 0.027 (2)
220 0.043 (4) 0.041 (1) 0.014 (1)
224 0.128 (12) 0.043 (3) 0.054 (4)
228 0.085 (8) 0.143 (10) 0.095 (7)
232 0.117 (11) 0.186 (13) 0.122 (9)
236 0.021 (2) 0.071 (5) 0.095 (7)
240 0.032 (3) 0.041 (1) 0.041 (3)
244 - 0.029 (2) -
288 - 0.041 (1) -
n = 94 n = 70 n = 74
n = Number of chromosomes, freq = Frequency, obs. No. = observed numberB
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Table 4: Statistical Analysis of ApoB, LPL and Leptin loci in normotensive, obese and hypertensive individuals.
No. of 
alleles 
observed
Predominant 
Allele 
(repeat/bp)
No. of 
genotypes 
observed
Predominant 
genotype (repeat/bp)
Observed 
Heterozygosity
Expected 
Heterozygosity
PIC PD H-W 
equilibrium
(P value)
ApoB locus
Normal (N = 33) 11 37 18 37-37 0.61 0.83 0.80 0.93 P = 0.623
Obese
(N = 34)
8 37 15 37-37, 37-39, 39-39 0.62 0.78 0.74 0.91 P = 0.358
Hypertensive
(N = 46)
13 39 24 37-37 0.63 0.83 0.78 0.92 P = 0.877
LPL locus
Normal (N = 29) 5 9 9 9-9 0.83 0.74 0.68 0.84 P = 0.156
Obese
(N = 33)
4 9 7 9-9 0.70 0.67 0.61 0.81 P = 0.094
Hypertensive
(N = 44)
6 9 10 9-10, 9-11 0.62 0.64 0.58 0.81 P = 0.939
Leptin locus
Normal (N = 29) 13 152, 156 23 152-156 0.76 0.85 0.82 0.94 P = 0.977
Obese
(N = 33)
14 152 23 152-152 0.83 0.86 0.83 0.94 P = 0.999
Hypertensive
(N = 44)
13 152 27 152-152, 224-228 0.77 0.88 0.87 0.94 P = 0.162
N = Number of samples, PIC = Polymorphic Information Content, PD = Power of Discrimination,
H-W:Hardy Weinberg
Table 5: Distribution of genotype frequency at Leptin locus.
Hypertensive
(N = 47)
Obese
(N = 35)
Normotensive
(N = 37)
Genotype (Class) Observed Frequency Observed Frequency Observed Frequency
I/I 0.383 (18) 0.257 (9) 0.351 (13)
II/II 0.277 (13) 0.314 (11) 0.270 (10)
I/II 0.340 (16) 0.429 (15) 0.378 (14)
The alleles of Leptin microsatellite polymorphism grouped into two classes with different size distribution: class I, 149-200 bp, class II, >217 bp. N = Number of individuals. Numbers in parantheses 
is the absolute number of observed frequency.BMC Medical Genetics 2009, 10:99 http://www.biomedcentral.com/1471-2350/10/99
Page 8 of 13
(page number not for citation purposes)
among hypertensive individuals with a frequency of
0.326, while allele 37 was found to be the predominant
one among obese and normal individuals with frequen-
cies of 0.353 and 0.288, respectively (table 3). Allele 11
was exclusively found in obese individuals though at a
lower frequency (0.029). Allele 58 was exclusively found
in hypertensive and obese individuals, at a lower fre-
quency of 0.011 and 0.029 respectively. Allele 56 was
exclusively detected in hypertensive group at a frequency
of 0.011. A total of 9 genotypes were exclusively present
among hypertensive individuals and 3 genotypes were
exclusively present among obese individuals as compared
to normal individuals. The predominant genotype among
hypertensive individuals was genotype 39-39, whereas
genotype 37-37 was the predominant one among normal
individuals. In contrast, there are three predominant gen-
otypes (37-37, 37-39 and 39-39) among obese individu-
als (table 4).
The observed heterozygosity was found to be moderate
(>0.61) in all the three groups. Under the assumption of
Hardy Weinberg equilibrium expectations, the expected
heterozygosity was calculated and was in the range of 0.78
to 0.83. The power of discriminations (PD) observed at
this locus was >0.90. Polymorphism Information Content
(PIC) of this locus was moderate and found to be in the
range of 0.74-0.80 (table 4).
LPL locus
At LPL locus, a total of six alleles (5 in normal, 4 in obese
and 6 in hypertensive) and 12 genotypes were observed
among these three groups (table 3, 4 and figure 1B). All
the three groups showed trimodal distribution of allele 9,
10 and 11. However, allele 9 was found to be the most
predominant allele among hypertensive, obese and nor-
mal individuals with frequencies of 0.523, 0.485 and
0.345, respectively. Allele 13 was exclusively observed
among hypertensive individuals although at a lower fre-
quency (0.011). A total of 10 genotypes were observed in
hypertensive group, 7 in obese group and 9 in normal
group (table 4). Predominant genotype was 9-9 in hyper-
tensive and obese group whereas two predominant geno-
types were found in normal individuals (9-10 and 9-11).
There were two genotypes (8-10 and 11-13) observed
exclusively observed among hypertensive individuals,
although at a lower frequency.
At LPL locus, the observed heterozygosity had moderate
values of 0.62 and 0.70 in hypertensive and obese groups,
respectively and comparatively a high value of 0.83 for
normal group. The expected heterozygosity was in the
range of 0.64 to 0.74. Polymorphic Information Content
(PIC) of this locus was moderate (range: 0.58 to 0.68),
whereas the Power of Discrimination (PD) was observed
to be >0.81 in all the three groups (table 4).
Relative telomere length in normal, obese and hypertensive individuals Figure 2
Relative telomere length in normal, obese and hypertensive individuals.
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Leptin locus
At Leptin locus a total of 17 alleles (13 in normal, 14 in
Obese and 13 in hypertensive) and 49 different genotypes
were observed (table 3, 4 and figure 1C). The most pre-
dominant allele in hypertensive and obese group was
allele 152 bp with a frequency of 0.213 and 0.257, respec-
tively, whereas the normal individuals showed a bimodal
distribution at allele 152 bp and 156 bp with a similar fre-
quency of 0.243. Allele 160 bp was exclusively observed
among hypertensive and obese group though at a lower
frequency. Alleles 244 bps and 288 bp were exclusively
found among obese individuals. Allele 172 bp was exclu-
sively found among hypertensive individuals (frequency
of 0.011). The Predominant genotypes were found to 152-
152 bp in obese (0.114) and 152-156 bp in normal
(0.135) whereas hypertensive group showed two predom-
inant genotypes (152-152 bp, 224-228) with a frequency
of 0.106 each. Interestingly, there were 12 exclusive geno-
types among hypertensive individuals and 10 exclusive
genotypes among obese individuals (data not shown).
At this locus, all the alleles were grouped into two classes
on the basis of its size (bp) distribution. Shorter alleles
were named as class I alleles which ranges from 149 to
200 bp, whereas longer alleles were called as class II alle-
les, which were >217 bp as described by Shintani et al
1996 and 2002 [6,33]. On that basis, there are three gen-
otypes namely, class I/I, II/II and I/II and the frequencies
were given in table 5. The frequency of genotype I/I was
significantly lower (P < 0.05) in obese individuals as com-
pared to normal and hypertensive group. Genotypes II/II
was observed at a marginally higher frequency among
obese individual though not significant as compared to
normal and hypertensive group. However, genotype I/II
had a significantly higher frequency (P < 0.05) in obese
group as compared to normal and hypertensive group.
Relative Telomere length
The relative telomere length was determined in a total of
93 individuals (58 males and 35 females). It included 26
normal, 27 obese and 40 hypertensive individuals. We
have performed regression analysis to study the relation-
ship between age and telomere length. Taking all the sam-
ples for consideration, our results showed a significant
decrease in the mean telomere length (R = 0.5166991, P <
0.001) with respect to age. Similar trend was also
observed when regression analysis of the telomere length
with respect to age was performed among male and
female individuals separately (male: R = 0.5216321, P <
0.001) and female (females: R = 0.5436911, P < 0.001).
The relative telomere length was determined in male and
female individuals from normal, obese and hypertensive
groups. The mean telomere length was observed to be
1.15 ± 0.027 in males and 1.13 ± 0.029 in females, which
were not statistically significant (P >0.05).
We have performed the analysis of covariance (ANCOVA)
in order to adjust the influence of age and gender on tel-
omere length. After adjusting the effect of age and gender,
the mean telomere length was observed to be 1.22 ± 0.14
(95% CI, 1.19-1.25) in normal, 1.20 ± 0.023 (95% CI,
1.16-1.25) in obese and 1.01 ± 0.021 (95% CI, 0.97- 1.06)
in hypertensive individuals (figure 2). The mean telomere
length observed in hypertensive group was significantly
different (P < 0.001) as compared to the values obtained
from normal and obese groups. By taking gender alone as
a variable the mean telomere length remained
unchanged.
Pair-wise comparisons were performed taking all the three
groups (normal, obese and hypertensive) into considera-
tion in order to find out the difference between the
groups, if any, with respect to telomere length. Our results
revealed that hypertensive group was statistically different
as compared to normal (p < 0.002) and obese (p < 0.001)
groups.
Discussion
Hypertension and obesity have strong genetic and multi-
ple environmental determinants. The fact that the preva-
lence of hypertension and obesity is on the rise mostly
due to life style, many genetic association studies have
been undertaken all over the world by choosing suitable
genetic markers from the candidate genes of hypertension
and obesity. The multicentric study by Indian Council of
Medical Research revealed that the prevalence rate in
urban as well as rural areas in India is on the rise [61].
Considering the diversity and unique founder population
in India, it is essential to carry out genetic association
research on hypertension and obesity. In the present
investigation, we report a genetic association study on
obese and hypertension using three candidate loci (ApoB,
LPL and Leptin). Since biological ageing has been associ-
ated with multifactorial diseases like essential hyperten-
sion and diabetes, we also have made an attempt to
determine the leukocyte telomere length to find out the
telomere length attrition, if any, in these individuals.
In the first part of our study we have compared the allele
frequencies of ApoB, LPL and Leptin loci in hypertensive,
obese groups as compared to normal individuals. This
analysis has helped us to understand the allele specific
association in the individuals studied. Interestingly, for
the first time, we are reporting two new alleles (9 and 11
repeats) at ApoB locus. The predominant alleles (37 and
39 repeats) were found to be the same in normal, hyper-
tensive and obese groups, which suggests that all the indi-
viduals belong to same founder population or with
similar genetic background. Investigation at allele 35 at
ApoB locus was significantly associated with clinical diag-
nosis of hypertensive patients in UAE Nationals [1] andBMC Medical Genetics 2009, 10:99 http://www.biomedcentral.com/1471-2350/10/99
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reported to be advantageous in younger adults [2],
whereas it could be dangerous in elders. DNA polymor-
phism study on various ethnic groups of Indian popula-
tion [62] did not show allele 35 as the predominant allele
at ApoB locus. Allele 35 did not seem to have any associ-
ation in the present study population. We have observed
approximately 21% alleles in hypertensive groups which
were >39 repeats as compared to ~10% each in obese and
normal individuals (p < 0.001). This suggests that higher
alleles > 39 may have strong association with hyperten-
sion in this particular study group from India. There are
reports which revealed that allele 50 (repeats) is associ-
ated with obese people [63]. But, we did not observe
allelic association at allele 50 (repeats) with obese indi-
viduals. The large allelic variation and allele specific asso-
ciation to hypertension and obese individuals makes this
informative locus suitable for genetic association studies.
At LPL locus, a trimodal distribution of alleles, (9, 10 and
11 repeats) in all the three groups showed the founder
population/genetic similarity. The frequency of the most
frequent allele (9 repeats) was significantly higher (p <
0.05) in hypertensive group as compared to normal indi-
viduals. In addition, allele 13 (repeats) was exclusively
found among the hypertensive group. These finding at
this locus is suggestive of allele specific association of this
locus with hypertensive individuals. Earlier only five alle-
les were detected at this locus [25,64], but our study
detected six alleles. The variability and allelic association
of this informative locus also suggests that it will be useful
for genetic association studies in diseases samples.
Leptin locus displayed high variability with large number
of alleles (15 alleles) in our samples as compared to other
populations in the world. Two classes of alleles: class I
(shorter alleles) and Class II (longer alleles) was reported
earlier [6,33]. Their study reported that the frequency of
class I alleles was higher in hypertensive group as com-
pared to control. The frequency of I/I genotype was signif-
icantly higher in hypertensive subjects independent of
diabetes but not in obese [6]. It has also been reported
that the frequency of class I alleles was significantly higher
in obese as compared to normal individuals [5]. Espe-
cially the genotype I/II was significantly increased among
obese as compared to normal and hypertensive individu-
als. In contrast, our study revealed a marginally lower fre-
quency of class I/I genotype among obese as compared to
normal and hypertensive individuals.
Another study had reported that leptin gene is not a major
contributor of hypertension in African-Americans [7]. But
in the present study, we report that genotype I/I occur at a
similar frequency in normal and hypertensive individuals,
which was significantly higher (p < 0.05) as compared to
obese individuals. In obese individuals, the frequency of
genotype II/II was significantly higher frequency (p <
0.001) as compared to normal and hypertensive individ-
uals. This suggests that there may be a strong association
of this genotype in obese individuals in Indian popula-
tion. However, further investigation is required with
larger number of samples using this polymorphic locus,
which is a suitable candidate for genetic association stud-
ies in Indian population.
In the second part of our study, we have determined the
telomere length among normal, obese and hypertensive
individuals using a recently developed real time quantita-
tive PCR. Since telomere length is an indicator of biologi-
cal aging in humans [65,66], it is worth pursuing research
on determining the causes of telomere attrition in age
related diseases. Telomere attrition has been reported due
to inflammation, exposure to infectious agents and other
types of oxidative stress, which damage telomeres and
impair their repair mechanisms [65,67]. It is also corre-
lated with DNA damage response [68] and reported to be
under genetic control which might play a role in mecha-
nisms that regulate pulse pressure, including vascular
aging [69].
Limited data is available on telomere shortening in hyper-
tension and obese individuals. Shorter telomere length
was observed in hypertensive individuals from Han Chi-
nese [48] and Southern Taiwan [49] population. Simi-
larly, loss of telomere length was reported in obese
women from United States and Puerto Rico as compared
to non obese-females [53]. In the present study, we report
that hypertensive individuals have a significantly shorter
telomere length (p < 0.001) as compared to normal and
obese individuals. We did not observe shorter telomere
length in obese individuals as compared to normal indi-
viduals. However, the causes of telomere shortening in
hypertensive individuals are not known at this stage.
Cumulative oxidative burden may affect telomere length
in hypertensive individuals. So it is important to under-
stand the biology of telomere attrition in multifactorial
disease like hypertension.
Telomere length can also be affected by many confound-
ing factors such as gender, lifestyle, diet, habits and stress.
Associations between telomere length and stress/aging
have significant implications for human health [41]. We
observed a decreasing trend in telomere length with the
increasing age. Since we have a limited sample size, the
effect of various age groups on telomere length was not
given separately for normal, obese and hypertensive indi-
viduals. Hence, we have analysed the telomere length in
all the individuals after adjusting the age. There are studies
showing significant difference in telomere length among
male and female adults. A study has shown that the tel-
omere length in females is significantly longer than malesBMC Medical Genetics 2009, 10:99 http://www.biomedcentral.com/1471-2350/10/99
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[42], although there are many studies which did not
reveal any significant difference between the telomere
length of male and female adults. In the present study, we
did not find any significant loss of telomere length among
male and female individuals in normal, obese and hyper-
tensive groups. We have not included smokers in our
study as smoking has been associated with telomere attri-
tion [52,70].
Perspectives
The present study illustrated association of some of the
alleles at ApoB, LPL and Leptin loci with hypertensive and
obese individuals in Indian population. The preliminary
study with a limited sample has shown shorter telomere
length in hypertensive individuals. Hence, further careful
analysis on larger samples is required to throw some
insight to the association of telomere length with hyper-
tension and obese. Furthermore, this study will help in
understanding the causative factor involved in leukocyte
telomere biology. Telomere length regulation is essential
for cell maintenance in humans, since telomere can lead
to a number of defects including impaired cell division.
Therefore studies on the mechanism of telomere length
attrition in diseases like hypertension, obese and diabetes
will provide immense understanding on its biological
role.
Conclusion
These three loci are excellent informative markers with
immense potential to be used in genetic association stud-
ies in India. Our data would provide useful information
to Indian population genetic databases as well as disease
association studies related to obese and hypertensive indi-
viduals. Telomere length measurement using real time
PCR did not reveal any significant loss of telomere length
in obese individuals, whereas, there may be association
between the telomere length and hypertensive individu-
als. However, sample size should be increased to give a
better understanding of the disease association and popu-
lation genetic studies. To our knowledge, this study is the
first report from Indian population dealing with associa-
tion of alleles with hypertension and obese and telomere
length determination in hypertensive and obese individu-
als using quantitative real time PCR.
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